Afayro 30mg Tablet

Afayro 30mg Tablet

Prescription requiredRx Required

Salt Composition: Afatinib

Expiry Date: 01/2028

Special offer

Buy at $67.83

$67.83

Inclusive of all taxes

28

About The Product

Lung Cancer, monotherapy

Description

Afayro 30mg tablet is an ant-cancer medication which is a prescription based medication used to treat non small cell lung cancer (NSCLC). It works by blocking the epidermal growth factor (EGFR) which is involved for the growth and multiplication of cancer cells, thereby helping to slow or stop tumor growth.

The active ingredient in the medication is Afatinib, which is a salt form used in the tablet.The medication is used alone as it is a monotherapy medication. Patient should take it exactly as prescribed by the doctor, all medical instructions carefully and report any side effects or unusual symptoms promptly.

Indication

Non small cell lung cancer (NSCLC)

Common side effects

  • Like other medication Afayro 30mg tablet cause various side effects, some may resolve on their own and some need proper medication to relieve the symptoms.
  • Consult the doctor If the symptoms worsen: ● Diarrhea ● Mouth sores ● Acne or skin rash ● Nausea and vomiting ● Fatigue ● Loss of appetite ● Abdominal pain ● Interstitial lung disease (ILD) ● Severe diarrhea or dehydration ● Liver problems ● Eye problems, such as corneal erosion or ulceration

Dosage and administration

  • Doctor recommend the correct dosage and duration of Afayro 30mg tablet based on the patient's medical condition and response to the treatment.
  • This tablet should be taken with a whole glass of water, do not crush or chew it take it as it is.
  • Never skip or double the dose without consulting the doctor to ensure safety and effectiveness of the treatment.

Mechanism of action

Afayro 30g tablet is a targeted therapy which specifically target on the cancer cells that is most commonly those with mutation in the EGFR (epidermal growth factor receptor). The medication block EGFR mutation gene which is the responsible for the growth of cancer cells in the body.

It helps prevent the growth and multiplication of tumor cells in the body.

Safety advice

Alcohol
Alcohol should not be taken while using Afayro 30mg tablet, as it interfere with the treatment outcomes in many patients.
Driving
Afayro 30mg tablet do not affect the driving but if you experience any of the side effects while using the medication, must consult the doctor instantly.
Pregnancy
Pregnant women should avoid using Afayro 30mg tablet because it harm the fetus and cause birth defects. Women who are pregnant and planning to be pregnant should consult the doctor before taking this medication.
Breast Feeding
Afayro 30mg tablet should not be taken by breastfeeding women. The drug may pass into breast milk and could potentially harm the nursing infant. Mothers either avoid feeding milk to their child or should consult the doctor before using the medication.
Kidney
Afayro 30mg is not harmful to kidney patient but the doctor should evaluate kidney function before and during treatment to ensure safety.
Liver
Afayro tablet is safe for liver patient but it is better to consult the doctor before using them to ensure safety and proper monitoring.

FAQs

Afayro 30mg tablet show various side effects such as diarrhea, mouth sores, fatigue, abdominal pain etc.

but they are manageable with proper care and regular medical guidance.

Reference

• Wecker, H., & Waller, C. F.

(2018). Afatinib.

Small Molecules in Oncology, 199-215. • Dungo, R. T., & Keating, G.

M. (2013).

Afatinib: first global approval. Drugs, 73(13), 1503-1515. • Wind, S., Schnell, D., Ebner, T., Freiwald, M., & Stopfer, P.

(2017). Clinical pharmacokinetics and pharmacodynamics of afatinib.

Clinical pharmacokinetics, 56(3), 235-250. • Nelson, V., Ziehr, J., Agulnik, M., & Johnson, M. (2013).

Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC. OncoTargets and therapy, 135-143. • Keating, G.

M. (2014).

Afatinib: a review of its use in the treatment of advanced non-small cell lung cancer. Drugs, 74(2), 207-221.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026